SUBSCRIBE
SUBSCRIBE
News   Drug Development

Cerulean Pharma Inc. Reports Second Quarter 2015 Corporate Highlights And Financial Results

August 7, 2015 | 
1 min read
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc. (Nasdaq: CERU) today provided an update on corporate activities during the quarter ended June 30, 2015.

Help employers find you! Check out all the jobs and post your resume.
Clinical research Phase I Phase II Earnings
MORE ON THIS TOPIC
Wood block with healthcare medical icon on blue background. Health care insurance concept
Infectious disease
Gilead, GSK/ViiV, Merck Present New HIV PrEP Frontiers at IAS25
July 15, 2025
 · 
4 min read
 · 
Tristan Manalac
Contemporary art collage. Conceptual design with young woman, motivated employee running forward to reach goal, professional success. Concept of business, career development, achievement
Obesity
Hengrui’s Dual GLP-1/GIP Elicits 17.7% Weight Loss in Phase III
July 15, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
World Management Team in office silhouette 3d rendering
Drug Development
The Gap Between the Administration’s Pro-Innovation Words and Policy
July 14, 2025
 · 
6 min read
 · 
Lori Ellis
3d rendering medical heart in yellow background
Cardiovascular disease
AstraZeneca’s Baxdrostat Pushes Blood Pressure Lower in Phase III Trial
July 14, 2025
 · 
1 min read
 · 
Dan Samorodnitsky